Online Hours

Hours displayed in:
Eastern Time (US & Canada)

All Participants - Welcome!

  • 9:00 AM - 9:30 AM

Room 1 - Computer Scientist, Operation Research Analyst, and Software Engineer/Office of Strategic Programs

  • 9:30 AM - 4:00 PM

Room 2 - Physicians and Clinical Analyst/Office of Medical Policy

  • 9:30 AM - 12:00 PM

Room 3 - Consumer Safety Officer and Pharmacist/Office of New Drugs

  • 9:30 AM - 12:00 PM

Room 4 - Engineering/Office of Compliance and Office of Translational Science

  • 1:00 PM - 4:00 PM
Register to view additional information about this organization

Register

About

At the Food and Drug Administration's Center for Drug Evaluation and Research (CDER, pronounced SEE-der), you can make a difference in protecting the health of the American people. We have an ongoing need for qualified individuals with backgrounds in health-related sciences, health policy, and information technology.

CDER's Public Health Mission

CDER's mission is to assure that safe and effective drugs are available to the American people. CDER promotes, protects, and enhances the health of the public through the drug development and evaluation process which:

  • Approves drugs for marketing that are effective, have had their adverse effects adequately studied, provide benefits that outweigh their risks, and are of high quality and have directions for use that are complete and honestly communicated.
  • Evaluates marketing applications in a timely fashion, with special priority to drugs for serious illness, especially if there is no adequate therapy. CDER shares with the regulated industry, scientific groups, and the public, the goal of identifying promising new drugs and developing them expeditiously.
  • Facilitates early access to promising drugs being developed for serious illnesses with no adequate therapy.
  • Promotes innovations and provides scientific leadership in the drug development process through collaborative work with the industry, academia and domestic foreign agencies and organizations.
  • Assures that the safety and rights of patients in drug studies are adequately protected.
  • Assures that product quality and safety are maintained after marketing and that new information about drugs is actively sought, evaluated, and communicated in a timely fashion.